142 related articles for article (PubMed ID: 4149759)
1. Adrenergic-induced vascular adjustments--initial and escape reactions. I. Influence of beta-adrenergic blocking agents on the intestinal circulation of the rat (in vivo).
Henrich H; Singbartl G; Biester J
Pflugers Arch; 1974 Jan; 346(1):1-12. PubMed ID: 4149759
[No Abstract] [Full Text] [Related]
2. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
Mouillé P; Cheymol G
C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
[No Abstract] [Full Text] [Related]
3. Adrenergic-induced vascular adjustments--initial and escape reactions. II. Role of beta-adrenergic receptors within different sections of the isolated intestinal vascular bed.
Singbartl G; Henrich H
Pflugers Arch; 1974 Jan; 346(1):13-24. PubMed ID: 4149758
[No Abstract] [Full Text] [Related]
4. [Inotropic effects of several adrenergic beta blockers in a dog subjected to electrosystolic cardiac impulse].
Cheymol G; Mouillé P; Schmitt H; Laubie M
Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):45-51. PubMed ID: 4148408
[No Abstract] [Full Text] [Related]
5. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
6. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
Adam KR; Boyles SM
Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
[No Abstract] [Full Text] [Related]
7. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
Klempt HW; Bender F
Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
[No Abstract] [Full Text] [Related]
8. Effects of Kö 1366 on the distribution of intrarenal blood flow in normal canine kidneys.
Nakamura M; Nose Y; Tomoike H; Shirai T; Kuroiwa A
Arzneimittelforschung; 1974 Sep; 24(9):1325-8. PubMed ID: 4154766
[No Abstract] [Full Text] [Related]
9. Effects of beta-adrenergic blocking agents on peripheral vascular resistance.
Rascher W; Mann JF; Schömig A; Dietz R; Lüth JB
Klin Wochenschr; 1978; 56 Suppl 1():87-90. PubMed ID: 32434
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism underlying the enchanced noradrenaline-overflow from the rabbit heart induced by the beta-adrenolytic drugs bupranolol and pindolol.
Wagner J; Reinhardt D; Schümann HJ
Res Exp Med (Berl); 1973 Jun; 160(4):261-8. PubMed ID: 4147104
[No Abstract] [Full Text] [Related]
11. Comparison of newly synthesized beta-adrenergic blockers, OPC 1085 and SQ 11725, with pindolol and propranolol in the blood-perfused canine SA node and papillary muscle preparations.
Hashimoto K; Kimura T; Yabuuchi Y
Jpn J Pharmacol; 1976 Aug; 26(4):504-6. PubMed ID: 12390
[No Abstract] [Full Text] [Related]
12. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
Salimi M
Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of renin inhibition by beta adrenergic blocking agents. Effects of dl-, d-, l-propranolol and pindolol on renin release.
Saruta T; Eguchi T; Nakamura R; Misumi J; Kondo K; Oka M
Jpn Heart J; 1980 Jan; 21(1):103-9. PubMed ID: 6102616
[TBL] [Abstract][Full Text] [Related]
14. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
[No Abstract] [Full Text] [Related]
17. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
Kulig A; Kostka-Trabka E; Gryglewski R
Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
[No Abstract] [Full Text] [Related]
18. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
19. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action.
Clark BJ; Saameli K; Troxler F
Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983
[No Abstract] [Full Text] [Related]
20. [Experimental research on the action of beta-adrenergic receptor blocking agents].
Valora N; Fidanza A; Floridi S
Arch Fisiol; 1969 Dec; 67(3):251-72. PubMed ID: 4394262
[No Abstract] [Full Text] [Related]
[Next] [New Search]
